Literature DB >> 9924847

Cardiac transgenic and gene-targeted mice as models of cardiac hypertrophy and failure: a problem of (new) riches.

S Izumo, T Shioi.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9924847     DOI： 10.1016/s1071-9164(98)90231-7

Source DB:  PubMed          Journal:  J Card Fail        ISSN： 1071-9164            Impact factor:   5.712


× No keyword cloud information.
  4 in total

1.  The conserved phosphoinositide 3-kinase pathway determines heart size in mice.

Authors:  T Shioi; P M Kang; P S Douglas; J Hampe; C M Yballe; J Lawitts; L C Cantley; S Izumo
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Development and validation of a novel technique for murine first-pass radionuclide angiography with a fast multiwire camera and tantalum 178.

Authors:  J L Lacy; T Nanavaty; D Dai; N Nayak; N Haynes; C Martin
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

3.  Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo.

Authors:  J Michael O'Donnell; Aaron Fields; Xianyao Xu; Shamim A K Chowdhury; David L Geenen; Jian Bi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-24       Impact factor: 4.733

Review 4.  Genetically modified mouse models used for studying the role of the AT2 receptor in cardiac hypertrophy and heart failure.

Authors:  Maria D Avila; James P Morgan; Xinhua Yan
Journal:  J Biomed Biotechnol       Date:  2011-04-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.